Royal DSM, a global science-based company active in health, nutrition and materials, today provides an update on the development of its Nutrition organization and several key positions to further support its growth plans.
In November 2015, DSM presented its Strategy 2018: Driving Profitable Growth. Key elements of the strategy for its Nutrition business are market-focused growth with global products and local solutions; continued innovation resulting in new ingredients, forms and custom-tailored premixes; expansion in new segments and geographies; as well as productivity improvements and cost reductions. As announced, the Nutrition strategy is designed to result in sales growth above the average market growth, with high single digit percentage EBITDA growth, an EBITDA margin of 18-20% and a high double digit basis point ROCE growth.
As part of the further execution of this strategy, DSM Nutritional Products has established a Global Products & Strategic Alliances Group under the leadership of André Bos, which includes product and category management as well as large, cross-industry business development programs. During 2015, under the leadership of Hans-Christian Ambjerg, the innovation efforts were further focused on a core number of technology and product/application platforms. Following a successful period of interim management by André Bos, the Human Nutrition & Health business will be led by Jeremy (Jinghuai) Xu, who recently joined from DuPont. DSM has also further strengthened the global sales organization at Human Nutrition & Health, especially in North America. The Animal Nutrition & Health business will be led by David Blakemore, who recently joined from Dow. David will build further on the great growth trajectory put in place by Mark Stock, who will be retiring in the autumn after an impressive 36-year career. The company’s ambitious growth plans for its Personal Care & Aroma Ingredients business will continue to be led by Wilfrid Gambade. In all three Nutritional Products businesses, DSM has developed a clear road map for further growth through global products, local solutions and strengthened customer management.
DSM Nutritional Products’ manufacturing and purchasing operations continue to be led by Luca Rosetto and remain focused on delivering important productivity improvements and cost reductions. Christian Nilsson joined the company from Tyco in the autumn of 2015, when he became the new CFO for DSM Nutritional Products, while Human Resources continues to be led by Jacoline van Blokland. Together with Philip Eykerman, DSM’s Executive Vice President Corporate Strategy, these key individuals are part of the Executive Leadership Team of DSM Nutritional Products, led by Chris Goppelsroeder, President and CEO of DSM Nutritional Products and also a member of the DSM Executive Committee.
DSM Food Specialties, active in bio-based ingredients such as enzymes, cultures, food preservation ingredients, and savory flavors, led by Ilona Haaijer, is executing its ambitious growth plans. The texturizing/hydrocolloids businesses, which are run from China, are also progressing well.
Feike Sijbesma, CEO Royal DSM said: “I am convinced that the Nutrition organization, under the leadership of DSM Board Member Stephan Tanda and DSM Nutritional Products President and CEO Chris Goppelsroeder, is well prepared to capture the attractive market growth opportunities for its businesses and to deliver on its communicated goals.”
Source: DSM
Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024. Allen will succeed Tobias Hestler, who has decided to step down from the role, citing a long-term health condition, the company said.
The group said that the bottling line, which adds 6,500 square metres to the existing 60,700-square-metre site, is the next necessary stage in the company’s international development. The leading brand in Campari Group’s global sales, demand for the Italian bitter apéritif has grown by 500% in the last decade.
The partnership will see Coca-Cola adopt new technology to foster innovation and productivity globally. Through the deal, Coca-Cola has made a $1.1 billion commitment to the Microsoft Cloud and its generative AI capabilities.
